Loading: 100%
Mylan N.V. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 35,000 (as per Q3 2016)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker MYLno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 173034384246
datesClosing price (adj.)
13.10.201737.95
11.10.201738.29
04.10.201737.80
27.09.201731.93
20.09.201731.39
13.09.201733.56
06.09.201732.25
30.08.201730.59
23.08.201730.32
16.08.201730.47
09.08.201732.08
02.08.201736.92
26.07.201739.19
19.07.201738.34
12.07.201738.58
05.07.201738.47
27.06.201738.43
20.06.201737.42
13.06.201737.77
06.06.201738.55
30.05.201739.36
23.05.201739.59
16.05.201739.15
09.05.201738.01
02.05.201738.17
25.04.201736.85
18.04.201737.03
11.04.201738.45
04.04.201738.70
28.03.201741.72
21.03.201741.67
14.03.201742.77
07.03.201743.33
28.02.201741.85
21.02.201742.30
14.02.201740.75
07.02.201739.39
31.01.201738.05
24.01.201735.81
17.01.201737.07
10.01.201738.95
03.01.201739.11
27.12.201637.58
19.12.201637.49
12.12.201637.13
05.12.201635.65
28.11.201636.74
21.11.201636.68
14.11.201638.44
07.11.201636.59
31.10.201636.50
24.10.201637.56
17.10.201636.44
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
37.95n/a
Market Capitalisation
in million USD
19,292n/a
Enterprise Value
in million USD
33,854n/a
Common Shares Outstanding
as per Apr 27, 2016
508,342,710n/a
Preferred Shares Outstanding
as per Apr 27, 2016
488,388,431n/a
Average Basic Shares Outstanding
TTM
501,975,000n/a
Average Diluted Shares Outstanding
TTM
513,875,000n/a
Index Membership
n/a
Business Summary
Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 10,300n/a
Gross Profit 4,425n/a
Operating Income 1,250n/a
EBITDA 2,637n/a
Net Profit 257n/a
Balance Sheet
Cash and Cash Equivalents 1,257n/a
Receivables 3,099n/a
Total Current Assets 7,965n/a
PP&E 2,284n/a
Total Assets 36,539n/a
Accounts Payable 1,255n/a
Current Debt 4,489n/a
Total Current Liabilities 9,554n/a
Long-Term Debt 11,329n/a
Total Liabilities 24,710n/a
Total Equity 11,829n/a
Cash Flow
Depreciation & Amortisation 1,387n/a
Change in Working Capital -128n/a
Operating Cash Flow 2,350n/a
Net Change in PP&E and Intangibles -395n/a
Investing Cash Flow -8,012n/a
Dividends Paid 0n/a
Financing Cash Flow 6,313n/a
Total Change in Cash 670n/a
Free Cash Flow 2,256n/a
Profitability Ratios
Gross Margin 43.0%n/a
Operating Margin 12.1%n/a
Net Profit Margin 2.5%n/a
Return on Equity 2.2%n/a
Return on Assets 0.7%n/a
Per Share Figures
Basic EPS 0.51n/a
Diluted EPS 0.50n/a
Sales per Share 20.52n/a
Book Value per Share 23.56n/a
FCF per Share 4.49n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 74.10n/a
Price to Sales Ratio 1.85n/a
Price to Book Value 1.61n/a
Price to Free Cash Flow 8.44n/a
Valuation Metrics
EV/EBITDA 12.84n/a
EV/Sales 3.29n/a
Book to Market Value 0.61n/a
Other Ratios
Current Ratio 83.4%n/a
Liabilities to Equity Ratio 208.9%n/a
Debt to Assets Ratio 43.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Revenue
6,909
7,720
9,429
Sales & Services Revenue
6,857
7,647
9,363
Financing Revenue
0
0
0
Other Revenue
53
73
67
Cost of revenue
-3,869
-4,192
-5,213
Cost of Goods & Services
0
0
0
Cost of Financing Revenue
0
0
0
Cost of Other Revenue
0
0
0
Gross Profit
3,040
3,528
4,216
Other Operating Income
0
0
0
Operating Expenses
-1,919
-2,128
-2,853
Selling, General & Administrative
-1,409
-1,626
-2,181
Selling & Marketing
0
0
0
General & Administrative
0
0
0
Research & Development
-508
-582
-672
Depreciation & Amortization
0
0
0
Provision For Doubtful Accounts
0
0
0
Other Operating Expense
-3
80
0
Operating Income (Loss)
1,121
1,401
1,364
Non-Operating Income (Loss)
-388
-378
-546
Interest Expense, net
-313
-333
-339
Interest Expense
0
0
0
Interest Income
0
0
0
Other Investment Income (Loss)
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
Income (Loss) from Affiliates
0
0
0
Other Non-Operating Income (Loss)
-75
-45
-206
Pretax Income (Loss), Adjusted
733
1,022
818
Abnormal Gains (Losses)
15
-48
97
Acquired In-Process R&D
0
0
0
Merger / Acquisition Expense
0
0
0
Abnormal Derivatives
0
0
0
Disposal of Assets
0
0
0
Early extinguishment of Debt
0
0
0
Asset Write-Down
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
Sale of Business
0
0
0
Legal Settlement
15
-48
97
Restructuring Charges
0
0
0
Sale of and Unrealized Investments
0
0
0
Insurance Settlement
0
0
0
Other Abnormal Items
0
0
0
Pretax Income (Loss)
747
975
915
Income Tax (Expense) Benefit, net
-121
-41
-68
Current Income Tax
0
0
0
Deferred Income Tax
0
0
0
Tax Allowance/Credit
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
Income (Loss) from Continuing Operations
627
933
848
Net Extraordinary Gains (Losses)
0
0
0
Discontinued Operations
0
0
0
XO & Accounting Charges & Other
0
0
0
Income (Loss) Including Minority Interest
627
933
848
Minority Interest
-3
-4
0
Net Income
624
929
848
Preferred Dividends
0
0
0
Other Adjustments
0
0
0
Net Income Available to Common Shareholders
624
929
848
Remarks
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
226
1,236
Cash & Cash Equivalents
n/a
226
1,236
Short Term Investments
n/a
0
0
Accounts & Notes Receivable
n/a
2,269
2,689
Accounts Receivable, Net
n/a
2,269
2,689
Notes Receivable, Net
n/a
0
0
Unbilled Revenues
n/a
0
0
Inventories
n/a
1,651
1,951
Raw Materials
n/a
0
0
Work In Process
n/a
0
0
Finished Goods
n/a
0
0
Other Inventory
n/a
0
0
Other Short Term Assets
n/a
2,296
597
Prepaid Expenses
n/a
2,296
597
Derivative & Hedging Assets
n/a
0
0
Assets Held-for-Sale
n/a
0
0
Deferred Tax Assets
n/a
0
0
Income Taxes Receivable
n/a
0
0
Discontinued Operations
n/a
0
0
Miscellaneous Short Term Assets
n/a
0
0
Total Current Assets
n/a
6,441
6,473
Property, Plant & Equipment, Net
n/a
1,786
1,984
Property, Plant & Equipment
n/a
0
0
Accumulated Depreciation
n/a
0
0
Long Term Investments & Receivables
n/a
0
0
Long Term Investments
n/a
0
0
Long Term Marketable Securities
n/a
0
0
Long Term Receivables
n/a
0
0
Other Long Term Assets
n/a
7,594
13,811
Intangible Assets
n/a
2,347
7,222
Goodwill
n/a
4,049
5,380
Other Intangible Assets
n/a
0
0
Prepaid Expense
n/a
0
0
Deferred Tax Assets
n/a
397
458
Derivative & Hedging Assets
n/a
0
0
Prepaid Pension Costs
n/a
0
0
Discontinued Operations
n/a
0
0
Investments in Affiliates
n/a
0
0
Miscellaneous Long Term Assets
n/a
800
752
Total Noncurrent Assets
n/a
9,379
15,795
Total Assets
n/a
15,821
22,268
Liabilities and owners' equity
Payables & Accruals
n/a
1,066 1066300000
1,202 1202000000
Accounts Payable
n/a
906 905600000
1,110 1109600000
Accrued Taxes
n/a
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
Other Payables & Accruals
n/a
161 160700000
92 92400000
Short Term Debt
n/a
2,804 2803600000
1,078 1078300000
Short Term Borrowings
n/a
331 330700000
1 1300000
Short Term Capital Leases
n/a
0 0
0 0
Current Portion of Long Term Debt
n/a
2,473 2472900000
1,077 1077000000
Other Short Term Liabilities
n/a
1,434 1434100000
1,842 1841900000
Deferred Revenue
n/a
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
1,434 1434100000
1,842 1841900000
Total Current Liabilities
n/a
5,304 5304000000
4,122 4122200000
Long Term Debt
n/a
5,700 5699900000
6,296 6295600000
Long Term Borrowings
n/a
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
Other Long Term Liabilities
n/a
1,541 1540600000
2,084 2084100000
Accrued Liabilities
n/a
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
Pensions
n/a
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
204 203900000
718 718100000
Derivatives & Hedging
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
1,337 1336700000
1,366 1366000000
Total Noncurrent Liabilities
n/a
7,241 7240500000
8,380 8379700000
Total Liabilities
n/a
12,545 12544500000
12,502 12501900000
Preferred Equity
n/a
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
4,486 4486100000
7,134 7134100000
Common Stock
n/a
273 273300000
6 5500000
Additional Paid in Capital
n/a
4,213 4212800000
7,129 7128600000
Other Share Capital
n/a
0 0
0 0
Treasury Stock
n/a
-3,858 -3857700000
-68 -67500000
Retained Earnings
n/a
3,615 3614500000
4,462 4462100000
Other Equity
n/a
-987 -987000000
-1,764 -1764300000
Equity Before Minority Interest
n/a
3,256 3255900000
9,764 9764400000
Minority Interest
n/a
20 20100000
1 1400000
Total Equity
n/a
3,276 3276000000
9,766 9765800000
Total Liabilities & Equity
n/a
15,821 15820500000
22,268 22267700000
Remarks restated on n/a restated on Feb 16, 2016 n/a restated on Nov 9, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Net Income/Starting Line
627
933
848
Net Income
0
0
0
Net Income From Discontinued Operations
0
0
0
Other Adjustments
0
0
0
Depreciation & Amortization
516
567
1,032
Non-Cash Items
453
697
791
Stock-Based Compensation
47
66
93
Deferred Income Taxes
-87
-315
-116
Other Non-Cash Adjustments
493
946
814
Change in Working Capital
-489
-1,182
-662
(Increase) Decrease in Accounts Receivable
-554
-939
-265
(Increase) Decrease in Inventories
-157
-148
-320
Increase (Decrease) in Accounts Payable
137
0
132
Increase (Decrease) in Other
85
-95
-208
Net Cash From Discontinued Operations (operating)
0
0
0
Cash from Operating Activities
1,107
1,015
2,009
Change in Fixed Assets & Intangibles
-309
-316
-361
Disposition of Fixed Assets & Intangibles
25
9
2
Disposition of Fixed Assets
25
9
2
Disposition of Intangible Assets
0
0
0
Acquisition of Fixed Assets & Intangibles
-335
-325
-363
Purchase of Fixed Assets
0
0
0
Acquisition of Intangible Assets
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
Net Change in Long Term Investment
-9
0
-29
Decrease in Long Term Investment
11
20
33
Increase in Long Term Investment
-19
-20
-62
Net Cash From Acquisitions & Divestitures
-1,262
-50
-693
Net Cash from Divestitures
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
Cash for Joint Ventures
0
0
0
Net Cash from Other Acquisitions
-1,262
-50
-693
Other Investing Activities
-289
-434
-487
Net Cash From Discontinued Operations (investing)
0
0
0
Cash from Investing Activities
-1,869
-800
-1,570
Dividends Paid
0
0
0
Cash From (Repayment of) Debt
1,636
-169
-1,274
Cash From (Repayment of) Short Term Debt, net
141
-108
-329
Cash From (Repayment of) Long Term Debt, net
1,494
-61
-945
Repayments of Long Term Debt
-3,480
-2,296
-4,484
Cash From Long Term Debt
4,975
2,235
3,539
Cash From (Repurchase of) Equity
-924
54
30
Increase in Capital Stock
76
54
98
Decrease in Capital Stock
-1,000
0
-68
Other Financing Activities
-19
-153
1,849
Net Cash From Discontinued Operations (financing)
0
0
0
Cash from Financing Activities
693
-267
605
Net Cash Before Disc. Operations and FX
-69
-53
1,044
Change in Cash from Disc. Operations and Other
0
0
0
Net Cash Before FX
-69
-53
1,044
Effect of Foreign Exchange Rates
11
-13
-33
Net Changes in Cash
-59
-66
1,011
Remarks
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo